| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |